Clinical Trials in Detroit

Showing 6721-6740 of 14,997 trials

Laboratory-Treated T Cells After Second-Line Chemotherapy in Treating Patients With HER2/Neu-Negative Metastatic Breast Cancer

NCT01022138

RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Treating a patient's T cells in the laboratory may help the T cells kill more tumor cells when they are put back in the body. Giving laboratory-treated T cells after chemotherapy may be an effective treatment for breast cancer. PURPOSE: This phase II trial is studying how well giving laboratory-treated T cells after second-line chemotherapy works in treating patients with HER2/neu-negative metastatic breast cancer.

Breast Cancer

Barbara Ann Karmanos Cancer Institute43 participantsStarted Mar 2010

Detroit, Michigan, United States

COMPLETED< 1 mile

Prediction Value of the BreathID 13C-Methacetin Breath Test for Hepatic Decompensation

NCT02084160

The objectives of this study are: * To evaluate the ability of the Methacetin Breath Test (MBT) to detect hepatic decompensation events * To evaluate the relationship between liver Biopsy and clinical outcome and show that the MBT has a better predictive ability of clinical outcome than liver biopsy. * To evaluate the ability of the MBT to predict each of the individual liver related complications.

Chronic Liver Disease

Meridian Bioscience, Inc.579 participantsStarted Mar 2014

Detroit, Michigan, United States • Charleston, South Carolina, United States • Richmond, Virginia, United States +1 more locations

Laboratory-Treated T Cells After Second-Line Chemotherapy in Treating Patients With HER2/Neu-Negative Metastatic Breast Cancer

Prediction Value of the BreathID 13C-Methacetin Breath Test for Hepatic Decompensation

Find Trials by Condition in Detroit

Bag Mode BreathID Hp Validation Versus Endoscopy in Detection of Helicobacter Pylori

The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System

A Study to Test Combination Treatments in People With Advanced Renal Cell Carcinoma

A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma

REPRISE IV: LOTUS Edge Valve System in Intermediate Surgical Risk Subjects

Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis

Mood Lifters: A Self Help Program

An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque Psoriasis

OLAParib COmbinations

Long-term, Open-label, Flexible-dose, Extension Study of Vortioxetine in Child and Adolescent Participants With Major Depressive Disorder (MDD) From 7 to 18 Years of Age

A Study to Assess the Efficacy and Safety of BIVV009 (Sutimlimab) in Participants With Primary Cold Agglutinin Disease Without A Recent History of Blood Transfusion

Exalenz Lab Mode System Compared to Biopsy for H.Pylori Detection

A Trial of INS068 in Patients With Type 2 Diabetes Not Adequately Controlled With One or Two Oral Antidiabetics

Multicenter,Single-arm Study to Evaluate Efficacy, Safety, & Pharmacokinetics of Denosumab in Children w/ OI

A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Production Lots and Dose Levels of BNT162b2 RNA-Based COVID-19 Vaccines Against COVID-19 in Healthy Participants

Formula Tolerance of Term Infants

Safety and Efficacy of APX005M With Gemcitabine and Nab-Paclitaxel With or Without Nivolumab in Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma

A Study Evaluating the Efficacy of Venetoclax Plus Ibrutinib in Participants With T-cell Prolymphocytic Leukemia